Article
A closed and single-use system for monocyte enrichment: potential for dendritic cell generation for clinical applications.
Cell Therapy Unit of EFS Ile de France-site Henri Mondor, 51 Avenue Marechal De Lattre de Tassigny, 94010 Creteil Cedex, France.
Transfusion (impact factor:
3.22).
05/2003;
43(4):481-7.
pp.481-7
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: Current approaches in dendritic cell generation and future implications for cancer immunotherapy.
[show abstract] [hide abstract]
ABSTRACT: The discovery of tumor-associated antigens, which are either selectively or preferentially expressed by tumors, together with an improved insight in dendritic cell biology illustrating their key function in the immune system, have provided a rationale to initiate dendritic cell-based cancer immunotherapy trials. Nevertheless, dendritic cell vaccination is in an early stage, as methods for preparing tumor antigen presenting dendritic cells and improving their immunostimulatory function are continuously being optimized. In addition, recent improvements in immunomonitoring have emphasized the need for careful design of this part of the trials. Still, valuable proofs-of-principle have been obtained, which favor the use of dendritic cells in subsequent, more standardized clinical trials. Here, we review the recent developments in clinical DC generation, antigen loading methods and immunomonitoring approaches for DC-based trials.Cancer Immunology and Immunotherapy 11/2007; 56(10):1513-37. · 3.70 Impact Factor -
Dataset: Current approaches in dendritic cell generation and future implications for cancer immunotherapy.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
1 hour
apheresis mononuclear cell products
Cobe Spectra Apheresis
Cobe Spectra Apheresis system
collected cell product
Collected MOs
custom disposable
DC differentiation potential
DC-based active immunotherapy
dendritic cells
elutriated MOs
enriched MOs
fast device
flow cytometry
good tissue practice
independent international laboratories
mixed WBC reaction assay
modified cell separator
MOs
surface markers